Skip to main content
. 2020 Nov 16;21(22):8620. doi: 10.3390/ijms21228620

Figure 7.

Figure 7

Schematic representation of the tyrosine kinase inhibitor (TKI)-based OFF-switch. The TKI dasatinib inhibits the phosphorylation of CD3ζ and ZAP70, which have a key role in the T-cell receptor (TCR) signaling pathway (Adapted from Wu et al., 2019).